LOCATIONS:

+34 948 255 400

+34 948 296 500

OPENING HOURS, VISITS AND CONTACT
Main door	7:00-22:30h.
External consultations	7:15-22:30h.
Emergency	24h.

+34 91 353 19 20

+34 91 350 86 77

OPENING HOURS, VISITS AND CONTACT
Main door	7:30-21:00h.
External Consultations	9:00-20:00h.
Emergency	24h.

Home >
Research and Clinical Trials >
Scientific publications >
Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response

Scientific publications

Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response

Dec 1, 2003 | Magazine: Haematologica

Agirre X, Fontalba A, Andreu EJ, Odero MD, Larráyoz MJ, Montiel C, Calasanz MJ, Fernández-Luna JL, Prósper F

No abstract available

CITA DEL ARTÍCULO Haematologica. 2003 Dec;88(12):1425-6

Navarre headquarters

Madrid headquarters